Better Social, Emotional Communication, Healthy Relationship and ASD Accommodation Skills: Emotional Intelligence ("EQ") Training for Autistic People and ASD Accommodation Training for People Who Care

December 20, 2025 updated by: Kairon Connect, PBC
Subjects are enrolled in pairs. Pairs consist of an autistic adult age 18-36 and a non-autistic learning partner who has a relationship with the autistic adult, such as a parent. The autistic adult in each pair receives the first stage of Kairon's online leadership training consisting of emotional literacy and healthy relationship topics. The learning partner in each pair receives Kairon's autism accommodation training while encouraging and providing feedback to their paired autistic adult. After training, both people in each pair evaluate the trainings' impacts on themselves and on their partner. Specifically, each autistic adult evaluates both the effectiveness of the leadership training they received and the effectiveness of the autism accommodation training that their paired learning partner received. Each learning partner evaluates both the effectiveness of the autism accommodation training they received and the effectiveness of the leadership training that their paired autistic adult received.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
20

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • United States
    • Pennsylvania
      • Wexford, Pennsylvania, United States, 15090
        • Recruiting
        • Training is all online and is available to participate in the study from anywhere in the US, run from a site in PA
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Participants are enrolled in pairs consisting of an autistic adult and their learning partner. Autistic adult age requirement is 18-36 years and the learning partner age requirement is >18 years.

Autistic Adult Inclusion Criteria:

Generally healthy;

With a community diagnosis of ASD from a licensed clinician, such as a developmental pediatrician, psychiatrist, clinical psychologist, or a neurologist. Below is a set of valid example criteria these professionals could use, but other instruments, tools or diagnostic techniques could be used:

For example, meeting DSM-5 criteria for ASD based on a DSM-5 ASD symptom checklist (APA 2013); Meeting International Classification of Diseases (ICD-11) for ASD (code 6A02)(Kamp-Becker, 2024); or a score in the ASD range on the Autism Diagnostic Observation Schedule 2 (ADOS-20)(Lord et al., n.d.).

Participants have:

Sufficient linguistic capability and technology fluency and capability to participate in an all-online intervention and associated assessments; Their own computer hardware, software and internet connection to allow access to online training; Availability of a non-ASD parent, guardian or adult with a similarly strong and trusting relationship ("learning partner") who, upon pre-enrollment interview, has sufficient linguistic capability and technology fluency and capability to participate in an all-online intervention and associated assessments and the willingness, time and energy to keep up with the coursework; Absence of a clinical anxiety diagnosis, such as <70 score on the ASEBA ASR Anxiety Problems score (or equivalent) or not having sufficient anxiety to be clinically evaluated; Verbal IQ ≥ 90 from a community test or using the Self-Administered Verbal IQ Test (SA-VIQT)(Logos et al., n.d.; openpsychometrics.org, n.d.), which can be administered entirely online and has convergent validity with Wechsler Abbreviated Scale of Intelligence - Second Edition (WASI-II)(Wechsler, n.d.); and Ability to provide consent in English as a primary language with an absence of cognitive impairment.

Autistic Adult Exclusion Criteria:

Candidates will be ineligible for the study if they are Participating in other emotional intelligence, emotional communication or behavioral intervention training during the month of this intervention; Unable to devote at least an average of 15-30 minutes per day for 5 days per week, except one day off in the third week, to do the training plus two sets of 60-90 minute online questionnaires; or Unable to comply with study procedures or unwilling to accept the standard Kairon platform terms of use.

Learning Partner Inclusion Criteria:

Selected by an ASD adult enrolled in the study; Generally healthy; Without a diagnosis of ASD Sufficient linguistic capability and technology fluency and capability to participate in an all-online intervention and associated assessments; Their own computer hardware, software and internet connection to allow access to online training; Ability to provide consent in English as a primary language with an absence of cognitive impairment.

Learning Partner Exclusion Criteria:

Candidates will be ineligible for the study if they are Participating in other ASD accommodation training during the month of this intervention; Unable to devote at least an average of 15-30 minutes per day for 5 days per week, except one day off during the third week, to do the training plus two sets of 60-90 minute online questionnaires; or Unable to comply with study procedures or unwilling to accept the standard Kairon platform terms of use.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Leadership training for autistic adult and autism accommodation training for learning partner
Device: Kairon leadership training for the autistic adult and Kairon autism accommodation training for the learning partner
Leadership training consists of emotional literacy and healthy relationship elements

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Training effectiveness
Time Frame: 55-85 minutes before and after training
Surveys of each autistic adult measure the effectiveness of the leadership training they received and the effectiveness of the autism accommodation training their paired learning partner received. Surveys of each learning partner measure the effectiveness of the autism accommodation they received and the effectiveness of the leadership training their paired autistic adult received.
55-85 minutes before and after training

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Usability
Time Frame: 5 minutes after training
Basic feedback on various aspects of the user experience during the training
5 minutes after training
Motivation
Time Frame: 5 minutes before training
Surveys of level of motivation from each participant
5 minutes before training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Kairon Connect, PBC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 30, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 28, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 28, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 20, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 20, 2025

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 2, 2026

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 2, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 20, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 1398838
  • BISA25000689 (Other Grant/Funding Number: Administration for Community Living (ACL))

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings